Gelonghui September 11 | Leadman (300289.SZ) said on the investor interactive platform that the company has supplied reagent products to Gaobo Hospital. The company is an important part of the controlling shareholder's “Five Ones” biomedical industry strategic layout. As one of the earliest domestic in vitro diagnostic product companies engaged in R&D, production and sales of biochemical diagnostic reagents, the company has core competitiveness in technology research and development, technical platforms, production processes and product quality, marketing and service networks, and product brands. In the future, the company will adhere to a sound business philosophy, focus on the field of in vitro diagnosis, actively integrate resources and strengthen cooperation on the basis of consolidating existing main business.